Status:
COMPLETED
Evaluation of Iodine Supplementation in Women With Pregnancy Associated With Gestational Diabetes
Lead Sponsor:
Centre Hospitalier Sud Francilien
Conditions:
Gestational Diabetes
Eligibility:
FEMALE
18+ years
Brief Summary
Iodine supplementation during pregnancy is recommended by the high health authority and by the World Health Organization during pregnancy. We would like to know if this supplementation is prescribed i...
Detailed Description
Physiological iodine requirements are increased in pregnant women, from 150 μg / day to 250 μg / day. The iodine intake is assessed by the iodine concentration in the urine, the target of which in pre...
Eligibility Criteria
Inclusion
- pregnant woman with gestational diabetes
- age ≥ 18 years
- subject informed of the study and not having opposed it.
Exclusion
- already known pathology of the thyroid
Key Trial Info
Start Date :
January 5 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 11 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04683211
Start Date
January 5 2021
End Date
May 11 2021
Last Update
May 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France, 91106